Tonight on The Brian Crombie Hour, Brian interviews Murat Croci. Murat is the co-founder and co-CEO of Ibex Biosciences and brings two decades of biotech leadership and five patents to advancing breakthrough treatments. Founded in 2015, Ibex is developing two transformative drugs: a single-dose malaria cure that blocks parasites from entering red blood cells, showing strong effectiveness in animal models, and an antibody drug conjugate targeting chemoresistant colorectal cancer. Using alpaca-based antibodies against CD147, this ADC achieves 100% efficacy in mouse models, eliminating tumors that typically recur in 35% of patients. The company focuses on colon cancer first, with potential expansion to melanoma and ovarian cancer. Brian closes this episode with some thoughts of his six year anniversary of the Brian Crombie Radio Hour.
